Header Logo

Connection

Mark Schmidt to Male

Back to Details
This is a "connection" page, showing publications Mark Schmidt has written about Male.
Mark Schmidt
Connection Strength
0.714
Male
  1. Economic Burden of Acute Gastroenteritis among Members of Integrated Healthcare Delivery System, United States, 2014-2016. Emerg Infect Dis. 2024 May; 30(5):968-973.
    View in: PubMed
    Score: 0.088
  2. A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system. PLoS One. 2018; 13(8):e0201805.
    View in: PubMed
    Score: 0.059
  3. A Ten-Year Case-Control Study of Passive Smoke Exposure as a Risk Factor for Pertussis in Children. Perm J. 2015; 19(3):59-63.
    View in: PubMed
    Score: 0.046
  4. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. J Adolesc Health. 2013 Nov; 53(5):637-41.
    View in: PubMed
    Score: 0.043
  5. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010 Nov 16; 28(49):7713-5.
    View in: PubMed
    Score: 0.034
  6. Persistent pruritus associated with worse quality of life in patients with chronic hepatitis. Liver Int. 2024 Feb; 44(2):577-588.
    View in: PubMed
    Score: 0.021
  7. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat. 2023 09; 30(9):746-755.
    View in: PubMed
    Score: 0.021
  8. HIV/AIDS surveillance and prevention: improving the characterization of HIV transmission. Public Health Rep. 2003 May-Jun; 118(3):197-204.
    View in: PubMed
    Score: 0.021
  9. Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States. J Viral Hepat. 2023 06; 30(6):512-519.
    View in: PubMed
    Score: 0.020
  10. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun. 2021 03; 5(3):400-411.
    View in: PubMed
    Score: 0.017
  11. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. 2020 May 22; 369:m1923.
    View in: PubMed
    Score: 0.017
  12. Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. Am J Gastroenterol. 2020 02; 115(2):262-270.
    View in: PubMed
    Score: 0.016
  13. Mental and physical health status among chronic hepatitis B patients. Qual Life Res. 2020 Jun; 29(6):1567-1577.
    View in: PubMed
    Score: 0.016
  14. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. J Viral Hepat. 2019 10; 26(10):1210-1217.
    View in: PubMed
    Score: 0.016
  15. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019 03 05; 68(6):956-963.
    View in: PubMed
    Score: 0.015
  16. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
    View in: PubMed
    Score: 0.015
  17. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Aliment Pharmacol Ther. 2019 03; 49(5):599-608.
    View in: PubMed
    Score: 0.015
  18. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018 06; 32(2):253-268.
    View in: PubMed
    Score: 0.015
  19. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States. Gastroenterology. 2018 02; 154(3):754-758.
    View in: PubMed
    Score: 0.014
  20. Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution. Dig Dis Sci. 2017 10; 62(10):2704-2712.
    View in: PubMed
    Score: 0.014
  21. Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017 Jun; 32(6):1250-1257.
    View in: PubMed
    Score: 0.014
  22. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study. Dig Dis Sci. 2016 12; 61(12):3469-3477.
    View in: PubMed
    Score: 0.013
  23. Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. Clin Infect Dis. 2016 11 01; 63(9):1205-1208.
    View in: PubMed
    Score: 0.013
  24. Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Dig Dis Sci. 2016 07; 61(7):2087-93.
    View in: PubMed
    Score: 0.013
  25. Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012-2013. PLoS One. 2016; 11(4):e0148395.
    View in: PubMed
    Score: 0.013
  26. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma. J Viral Hepat. 2016 09; 23(9):718-29.
    View in: PubMed
    Score: 0.013
  27. Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection. Clin Gastroenterol Hepatol. 2016 07; 14(7):1044-1055.e3.
    View in: PubMed
    Score: 0.012
  28. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus. Clin Infect Dis. 2016 Feb 01; 62(3):289-297.
    View in: PubMed
    Score: 0.012
  29. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study. Am J Gastroenterol. 2015 Aug; 110(8):1169-77; quiz 1178.
    View in: PubMed
    Score: 0.012
  30. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention. Hepatology. 2015 May; 61(5):1479-84.
    View in: PubMed
    Score: 0.012
  31. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology. 2015 Mar; 61(3):802-11.
    View in: PubMed
    Score: 0.012
  32. Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS). J Community Health. 2014 Oct; 39(5):914-21.
    View in: PubMed
    Score: 0.011
  33. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014 Dec; 21(12):917-20.
    View in: PubMed
    Score: 0.011
  34. Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin Infect Dis. 2014 Oct; 59(7):976-81.
    View in: PubMed
    Score: 0.011
  35. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014 Dec; 21(12):930-7.
    View in: PubMed
    Score: 0.011
  36. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010 Jan 15; 50(2):184-91.
    View in: PubMed
    Score: 0.008

© 2024 Kaiser Permanente